These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 37062910)

  • 1. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.
    Dite GS; Spaeth E; Murphy NM; Allman R
    Prostate; 2023 Jul; 83(10):962-969. PubMed ID: 37062910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a prostate cancer polygenic risk score.
    Black MH; Li S; LaDuca H; Lo MT; Chen J; Hoiness R; Gutierrez S; Tippin-Davis B; Lu HM; Gielzak M; Wiley K; Shi Z; Wei J; Zheng SL; Helfand BT; Isaacs W; Xu J
    Prostate; 2020 Nov; 80(15):1314-1321. PubMed ID: 33258481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
    Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
    Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma risk prediction based on a polygenic risk score and clinical risk factors.
    Wong CK; Dite GS; Spaeth E; Murphy NM; Allman R
    Melanoma Res; 2023 Aug; 33(4):293-299. PubMed ID: 37096571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study.
    Cheng Y; Wu L; Xin J; Ben S; Chen S; Li H; Zhao L; Wang M; Cheng G; Du M
    J Transl Med; 2024 Apr; 22(1):366. PubMed ID: 38632662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast and prostate cancer risk: The interplay of polygenic risk, rare pathogenic germline variants, and family history.
    Hassanin E; May P; Aldisi R; Spier I; Forstner AJ; Nöthen MM; Aretz S; Krawitz P; Bobbili DR; Maj C
    Genet Med; 2022 Mar; 24(3):576-585. PubMed ID: 34906469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.
    Ruan X; Huang D; Huang J; Tsu JH; Na R
    J Transl Med; 2023 Jul; 21(1):446. PubMed ID: 37415201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.
    Rumpf F; Plym A; Vaselkiv JB; Penney KL; Preston MA; Kibel AS; Mucci LA; Salari K
    J Urol; 2024 Jun; 211(6):754-764. PubMed ID: 38598641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of a glaucoma polygenic risk score in four population-based European-ancestry cohorts.
    de Vries VA; Hanyuda A; Vergroesen JE; Do R; Friedman DS; Kraft P; Turman C; Luo YL; Tran JH; Liefers B; Wong SH; Lee RH; Zebardast N; Klaver CCW; Segrè AV; Pasquale LR; Wiggs JL; Kang JH; Ramdas WD
    Ophthalmology; 2024 Aug; ():. PubMed ID: 39128550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal improvement in coronary artery disease risk prediction in Chinese population using polygenic risk scores: evidence from the China Kadoorie Biobank.
    Yang S; Sun D; Sun Z; Yu C; Guo Y; Si J; Sun D; Pang Y; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Pang Z; Schmidt D; Stevens R; Clarke R; Chen J; Chen Z; Lv J; Li L;
    Chin Med J (Engl); 2023 Oct; 136(20):2476-2483. PubMed ID: 37200020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model.
    Hung RJ; Warkentin MT; Brhane Y; Chatterjee N; Christiani DC; Landi MT; Caporaso NE; Liu G; Johansson M; Albanes D; Marchand LL; Tardon A; Rennert G; Bojesen SE; Chen C; Field JK; Kiemeney LA; Lazarus P; Zienolddiny S; Lam S; Andrew AS; Arnold SM; Aldrich MC; Bickeböller H; Risch A; Schabath MB; McKay JD; Brennan P; Amos CI
    Cancer Res; 2021 Mar; 81(6):1607-1615. PubMed ID: 33472890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic risk scores for prediction of breast cancer in Korean women.
    Jee YH; Ho WK; Park S; Easton DF; Teo SH; Jung KJ; Kraft P
    Int J Epidemiol; 2023 Jun; 52(3):796-805. PubMed ID: 36343017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer risk prediction using a polygenic risk score.
    Sipeky C; Talala KM; Tammela TLJ; Taari K; Auvinen A; Schleutker J
    Sci Rep; 2020 Oct; 10(1):17075. PubMed ID: 33051487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort.
    Wu Y; Ruan X; Gao P; Da H; Fang Z; Xu D; Jiang H; Ding Q; Lin X; Lu D; Na R
    Clin Genet; 2023 Jun; 103(6):636-643. PubMed ID: 36840471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk.
    Chen X; Heisser T; Cardoso R; Hoffmeister M; Brenner H
    JAMA Netw Open; 2023 Oct; 6(10):e2339670. PubMed ID: 37878311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
    Lindström S; Schumacher FR; Cox D; Travis RC; Albanes D; Allen NE; Andriole G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Crawford ED; Diver WR; Gaziano JM; Giles GG; Giovannucci E; Gonzalez CA; Henderson B; Hunter DJ; Johansson M; Kolonel LN; Ma J; Le Marchand L; Pala V; Stampfer M; Stram DO; Thun MJ; Tjonneland A; Trichopoulos D; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Hayes RB; Severi G; Haiman CA; Chanock SJ; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):437-44. PubMed ID: 22237985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and evaluation of the functional polygenic risk score for gastric cancer in a prospective cohort of the European population.
    Gu Y; Yan C; Wang T; Hu B; Zhu M; Jin G
    Chin Med J (Engl); 2023 Jul; 136(14):1671-1679. PubMed ID: 37394533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry.
    Pagadala MS; Linscott JA; Talwar JV; Seibert TM; Rose B; Lynch J; Panizzon M; Hauger R; Hansen MH; Sammon JD; Hayn MH; Kader K; Carter H; Ryan ST
    BMC Cancer; 2022 Dec; 22(1):1289. PubMed ID: 36494783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer risk prediction based on complete prostate cancer family history.
    Albright F; Stephenson RA; Agarwal N; Teerlink CC; Lowrance WT; Farnham JM; Albright LA
    Prostate; 2015 Mar; 75(4):390-8. PubMed ID: 25408531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.